Haoma Medica

Haoma Medica is a UK-based biotechnology company focused on the treatment of osteoporosis and osteopenia, as well as blood coagulation management. The company's developed drug, called NaQuinate, is a novel compound designed for low-dose oral administration. As a natural product, NaQuinate preserves both bone mass and bone structure, and the safety of this treatment holds significant potential for addressing the serious challenges of long-term osteoporosis therapy.